Effect of cervical vagal nerve stimulation on defibrillation energy: A possible adjunct to efficient defibrillation

Japanese Heart Journal

Volumn 44, Issue 1, 2003, Pages 91-100

  Murakawa, Yuji ^a   Yamashita, Takeshi ^a   Ajiki, Kohsuke ^a   Hayami, Noriyuki ^a   Omata, Masao ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autonomic nerve system; Defibrillation; Defibrillation threshold; Implantable cardioverter defibrillator

Indexed keywords

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; DEFIBRILLATION; DISEASE DURATION; ELECTRIC CURRENT; ELECTRIC POTENTIAL; ELECTROCARDIOGRAPHY MONITORING; ELECTRODE; ELECTROSTIMULATION THERAPY; HEART VENTRICLE FIBRILLATION; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; VAGUS NERVE STIMULATION; ANIMAL; CARDIOVERSION; DEFIBRILLATOR; DOG; HEART FUNCTION TEST; METHODOLOGY; TRANSCUTANEOUS NERVE STIMULATION; VAGUS NERVE;

ANIMALS; DEFIBRILLATORS, IMPLANTABLE; DOGS; ELECTRIC COUNTERSHOCK; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; VAGUS NERVE;

EID: 0037263750     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.44.91     Document Type: Article

References (13)

1. Ruffy R, Schechtman K, Monje E. Beta-adrenergic modulation of direct defibrillation energy in anesthetized dog heart. Am J Physiol 1985; 248: H674-7.
2. Ruffy R, Schechtman K, Monje E, Sandza J. Adrenergically mediated variations in the energy required to defibrillate the heart: observations in closed-chest, non anesthetized dogs. Circulation 1986; 73: 374-80.
3. Rattes MF, Sharma AD, Klein GJ, Szabo T, Jones DL. Adrenergic effects on internal cardiac defibrillation threshold. Am J Physiol 1987; 253: H500-6.
4. Wang M, Dorian P, Ogilvie RI. Isoproternol increases defibrillation energy requirements in dogs. J Cardiovasc Pharmacol 1992; 19: 201-8.
5. Morrillo CA, Jones DL, Klein GJ. Effects of autonomic manipulation on ventricular fibrillation and internal cardiac defibrillation thresholds in pigs. PACE 1996; 19: 1355-62.
6. Sezaki K, Murakawa Y, Inoue H, et al. Effect of isoproterenol on facilitation of electrical defibrillation by E-4031. J Cardiovasc Pharmacol 1995; 25: 393-6.
7. Sousa J, Kou W, Calkins H, Rosenheck S, Kadish A, Morady F. Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. Am J Cardiol 1992; 69: 509-12.
8. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 1995; 45: 224-30.
9. McLachalan RS. Vagus nerve stimulation for intractable epilepsy: a review. J Clin Neurophysiol 1997; 14: 358-68.
10. Opthof T, Ramdat AR, Coronel R, et al. Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation. Circ Res 1991; 68: 1204-15.
11. Opthof T, Dekker LR, Coronel R, Vermeulen JT, van Capelle FJL, Janse MJ. Interaction of sympathetic and parasympathetic nervous system on ventricular refractoriness assessed by local fibrillation intervals in the canine heart. Cardiovasc Res 1993; 27: 753-9.
12. Rosenshtrakh L, Danilo P, Anyukhovski EP, et al. Mechanism for vagal modulation of ventricular repolarization and of coronary occlusion-induced lethal arrhythmias in cats. Circ Res 1994; 75: 722-32.
13. Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res 1972; 29: 437-45.